Understanding Your FNAH Diagnosis
At a Glance
FNAH is a rare genetic form of overactive thyroid caused by a TSHR gene change that can keep the thyroid switched on. Negative Graves’ antibodies, absent eye symptoms, persistent disease, and family patterns can help point to the diagnosis.
Receiving a diagnosis of Familial Non-Autoimmune Hyperthyroidism (FNAH) often marks the end of a long and confusing journey. For many, it follows years of being told they have Graves’ disease (the most common cause of an overactive thyroid), only for the standard treatments to fail or for blood tests to repeatedly come back without the expected antibodies [1][2].
Scope of this guide: This guide covers the diagnosis and management of FNAH, a rare genetic cause of non-autoimmune hyperthyroidism. Management differs by age and specific genotype. This guide does not replace the advice of your endocrinologist or genetic counselor.
If you feel a sense of relief—or even frustration—at finally having a genetic answer, you are not alone. This is an exceptionally rare condition. As of recent medical reviews, only a small number of families have been documented in the global medical literature [3][4]. Because it is so rare, many experienced endocrinologists may never have encountered a case in their entire careers.
The “Always-On” Switch
To understand FNAH, it helps to think of your thyroid like a lamp. In a healthy person, the brain sends a signal called TSH (Thyroid-Stimulating Hormone) to “plug in” the lamp and turn on the light. In Graves’ disease, the body’s immune system mistakenly creates antibodies that act like a faulty finger constantly pressing the “on” button.
In FNAH, the problem is different. You have a genetic variation in your TSHR (TSH receptor) gene [1]. This gene provides the instructions for the “socket” on your thyroid cells where the TSH signal is supposed to land. Because of this genetic change, the socket is often stuck in the “on” position, even when there is no signal from the brain and no antibodies present [5][2]. Your thyroid is essentially “leaking” or overproducing hormones because its internal machinery has difficulty turning itself off.
Clues That Point Away From Graves’ Disease
FNAH is often hidden in plain sight because its symptoms—racing heart, anxiety, weight loss, and heat intolerance—look exactly like other forms of hyperthyroidism (an overactive thyroid). However, several key factors often serve as clues:
- Negative Antibodies: Unlike Graves’ disease, FNAH is “non-autoimmune.” This means the common blood tests for TRAb or TSI (antibodies that stimulate the thyroid) will usually come back negative [1][6]. While a strong clue, negative antibodies do not rule out Graves’ completely.
- No Eye Symptoms: Most patients with FNAH do not develop thyroid eye disease (bulging or inflamed eyes), which is a common sign doctors look for when diagnosing Graves’ [2].
- The Relapse Cycle: While Graves’ disease can sometimes go into remission, FNAH is persistent. Patients often find that their hyperthyroidism returns when they try to lower or stop their antithyroid medication [1][7].
- Family Patterns: Because it is an autosomal dominant condition, it often runs through generations. If one parent has the variant, each child has a 50% chance of inheriting it [8]. However, it can also appear de novo, meaning a person is the first in their family to have the mutation [9].
A Spectrum of Experience
Even within the same family, FNAH does not look the same for everyone. This is known as variable expressivity [10]. One family member might be diagnosed as a toddler due to rapid growth and a high heart rate, while another might not be diagnosed until they are older adults with only mild symptoms [1][11].
Identifying the genetic variant provides a clear roadmap. It explains why past treatments might not have worked as expected and allows your care team to manage the specific mechanism of your thyroid. Identifying this variant also allows for cascade testing, helping other family members get diagnosed earlier [8][4].
Common questions in this guide
What is familial non-autoimmune hyperthyroidism (FNAH)?
How can doctors tell FNAH apart from Graves’ disease?
Is FNAH inherited, and could my children have it?
What symptoms can FNAH cause?
Why does my hyperthyroidism come back when I lower my medicine?
How should FNAH be monitored over time?
Get notified when new evidence is published on Familial hyperthyroidism due to mutations in TSH receptor.
We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.
References
References (11)
- 1
TSHR Gly413Ser in familial nonautoimmune hyperthyroidism: a case report.
Kelp O, Førsvoll J, Bischof F, et al.
Journal of pediatric endocrinology & metabolism : JPEM 2026; doi:10.1515/jpem-2025-0617.
PMID: 42665942 - 2
Novel presentation of the c.1856A > G (p.Asp619Gly) TSHR gene-activating variant: relapsing hyperthyroidism in three subsequent generations manifesting in early childhood and an in vitro functional study.
Bezdicka M, Kleiblova P, Soucek J, et al.
Hormones (Athens, Greece) 2021; (20(4)):803-812 doi:10.1007/s42000-021-00299-x.
PMID: 34142359 - 3
Familial Non-autoimmune Hyperthyroidism in Family Members Across Four Generations Due To a Novel Disease-causing Variant in The Thyrotropin Receptor Gene.
Malej A, Avbelj Stefanija M, Bratanič N, Trebušak Podkrajšek K
Balkan journal of medical genetics : BJMG 2020; (23(2)):87-92 doi:10.2478/bjmg-2020-0022.
PMID: 33816077 - 4
Report of a family with three generations of undiagnosed familial nonautoimmune hyperthyroidism.
Stephenson A, Punjwani Z, Eszlinger M, et al.
Endocrinology, diabetes & metabolism case reports 2021; (2021()).
PMID: 34866058 - 5
Familial Non-Autoimmune Hyperthyroidism Caused by an Extracellular Domain Variant (p.Leu267Phe) of the TSH Receptor.
Shimura K, Ichihashi Y, Abe K, et al.
Hormone research in paediatrics 2026; (99(5)):623-631 doi:10.1159/000544836.
PMID: 39987906 - 6
An A627V-activating mutation in the thyroid-stimulating hormone receptor gene in familial nonautoimmune hyperthyroidism.
Shin JH, Seo GH, Oh SH, et al.
Annals of pediatric endocrinology & metabolism 2020; (25(4)):282-286 doi:10.6065/apem.2040076.038.
PMID: 33401884 - 7
Non-Autoimmune Hyperthyroidism Associated With a Novel Germline Mutation (D633N) in the TSH Receptor.
Mori S, Osaki Y, Fukazawa H, et al.
Case reports in endocrinology 2026; (2026()):3274433 doi:10.1155/crie/3274433.
PMID: 42367683 - 8
Inheritable and sporadic non-autoimmune hyperthyroidism.
Ferraz C, Paschke R
Best practice & research. Clinical endocrinology & metabolism 2017; (31(2)):265-275 doi:10.1016/j.beem.2017.04.005.
PMID: 28648513 - 9
Novel germline mutation (Leu512Met) in the thyrotropin receptor gene (TSHR) leading to sporadic non-autoimmune hyperthyroidism.
Roberts SA, Moon JE, Dauber A, Smith JR
Journal of pediatric endocrinology & metabolism : JPEM 2017; (30(3)):343-347.
PMID: 28195550 - 10
Familial Nonautoimmune Hyperthyroidism Due to a TSH Receptor Gene Pathogenic Variant.
Takahashi S, Nishihara E, Fukata S, et al.
JCEM case reports 2024; (2(10)):luae167 doi:10.1210/jcemcr/luae167.
PMID: 39301178 - 11
Familial neonatal nonautoimmune hyperthyroidism due to a gain-of-function (D619G) thyrotropin-receptor mutation.
Taha D, Adhikari A, Flore LA
Journal of pediatric endocrinology & metabolism : JPEM 2021; (34(2)):267-271 doi:10.1515/jpem-2020-0291.
PMID: 33180037
This page is for informational purposes only and does not constitute medical advice. It explains FNAH and TSHR-related findings; your endocrinologist and genetic counselor should interpret your results and guide treatment.